*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Antibiofilm studies of zerumbone against polymicrobial biofilms of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans.

Author: HASYRUL HAMZAH, TRIANA HERTIANI, SYLVIA UTAMI TUNJUNG PRATIWI, TITIK NURYASTUTI, ANDAYANA PUSPITASARI GANI
Abstract: Zerumbone is an essential oil component of Zingiber zerumbet (L.) Smith which has been reported as a potential antimicrobial. Research on exploring its potency as antibiofilm against polymicrobial culture, in vitro has been conducted. Its wide spectrum efficacy on inhibition and eradication towards polymicrobial biofilm and polymicrobial biofilm on catheters of Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Candida albicans in an aerobic environment has been evaluated. Assays on determining the biofilm inhibition and eradication have been as a microdilution assay. A minimum biofilm inhibition concentration, which caused 50 % inhibition (MBIC50) and a minimum biofilm eradication concentration, which caused 50% eradication (MBEC50) were determined by using crystal violet as staining and read on a microplate reader at 590 nm. Furthermore, an analysis using the Scanning Electron Microscope (SEM) has been conducted to evaluate the mechanism of effect. Results showed that zerumbon 1 % showed antibacterial activity (planktonic) against aerobic microbes: S.aureus, P.aeruginosa, E. coli, and C. albicans were 88.17 ± 0.01, 84.90 ± 0.01, 68.21 ± 0.03, 86.02 ± 0.02, Zerumbone can inhibit and degrade monospecies and polymicrobial biofilm as 24 and 48 h in comparison to control (nystatin and chloramphenicol). SEM analyses confirmed the compound capability to disrupt the extracellular polymeric substance (EPS).
Keyword: zerumbone, antibiofilms, biofilms polymicrobial, SEM
DOI: https://doi.org/10.31838/ijpr/2020.SP1.211
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free